The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.
about
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - SummaryRisk scoring for the primary prevention of cardiovascular diseasePCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular diseaseFixed-dose combination therapy for the prevention of cardiovascular diseaseDietary advice for reducing cardiovascular riskDietary advice for reducing cardiovascular riskPotential increased risk of cancer from commonly used medications: an umbrella review of meta-analysesStatin-induced diabetes: incidence, mechanisms, and implicationsUnmet Needs in LDL-C Lowering: When Statins Won't Do!2015 Korean Guidelines for the Management of Dyslipidemia: Executive Summary (English Translation)Clinical efficacy and safety of evolocumab for low-density lipoprotein cholesterol reductionComparative effectiveness research and its utility in In-clinic practiceThe Interaction Between Statins and Exercise: Mechanisms and Strategies to Counter the Musculoskeletal Side Effects of This Combination TherapyPrevalence, Treatment, and Control of Hypercholesterolemia in High Cardiovascular Risk Patients: Evidences from a Systematic Literature Review in SpainUse of statins and the incidence of type 2 diabetes mellitusStatins for primary cardiovascular prevention in the elderlyEffect of Low-Density Lipoprotein Cholesterol Lowering by Ezetimibe/Simvastatin on Outcome Incidence: Overview, Meta-Analyses, and Meta-Regression Analyses of Randomized TrialsImplementation of the 2013 American College of Cardiology/American Heart Association Blood Cholesterol Guideline Including Data From the Improved Reduction of Outcomes: Vytorin Efficacy International TrialCholesterol confusion and statin controversyEgg consumption and risk of coronary heart disease and stroke: dose-response meta-analysis of prospective cohort studiesGenetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic reviewStatins as regulators of redox state in the vascular endothelium: beyond lipid loweringBenefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetesThe Year in Cardiology 2012: focus on cardiovascular disease preventionEvolution of lipid management guidelines: evidence might set you freeStatin use and risk of kidney cancer: a meta-analysis of observational studies and randomized trialsCardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An updateThe role of T and B cells in human atherosclerosis and atherothrombosisPrimary prevention with statins in cardiovascular diseases: A Saudi Arabian perspectiveEfficacy of intensive control of glucose in stroke prevention: a meta-analysis of data from 59,197 participants in 9 randomized controlled trialsContributions of risk factors and medical care to cardiovascular mortality trendsRole of colesevelam in combination lipid-lowering therapyNon-cardiovascular effects associated with statinsHow do we improve patient compliance and adherence to long-term statin therapy?Repurposing Treatments to Enhance Innate Immunity. Can Statins Improve Neutrophil Functions and Clinical Outcomes in COPD?Overview of guidelines for the management of dyslipidemia: EU perspectivesSilymarin in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsPCSK9 inhibitors in the prevention of cardiovascular diseaseUnmet need in the hyperlipidaemia population with high risk of cardiovascular disease: a targeted literature review of observational studiesMendelian Randomization and Type 2 Diabetes
P2860
Q22241786-B6B5F04B-B882-42DB-B4C8-1F4C737B58C2Q24186884-CAECA556-66DE-40C6-8865-70098484A828Q24187425-A0759E5D-6D14-4739-8D3F-2418B39CB094Q24195065-22D26514-F14A-413E-B76C-799797B9E2A5Q24198838-08B435D8-2F0B-40D3-B2E9-38F8345B8A8BQ24201921-A967A079-DE58-4A6B-8A97-C59605E13A54Q24289205-32B3DBEC-AE07-4F59-A594-46C22A80F67AQ26740677-83597E85-FD3B-4B0C-8C2E-D952BE3C39F1Q26741705-7F9D7FCC-12EA-421B-8187-BC8BE00FA28AQ26747559-6F365C92-3870-4457-A337-8F9559112F79Q26752950-5CF6CAFE-8AAA-4FA8-80F1-2B82F17A74FDQ26767184-36C7215E-C7EF-4B58-87B0-B58A83449B7DQ26771168-693D0CD8-E216-4917-B529-98C32C111751Q26779403-EE1839F7-E99E-4149-BAF9-94B3E0EF37A6Q26783136-8A87D805-9AFB-4BB6-AE60-DCD2645F2B08Q26783401-E9E125B9-679E-4B39-9986-0101C65C41D7Q26797486-8CA4B070-7CCB-4795-A2C3-FD6562287037Q26801245-0A45E3B8-296A-4276-981E-5DE3C552FA79Q26801620-EAA3BC6E-F147-4C20-AB90-ED3131D71A5AQ26823037-709359D9-D78F-43B3-B97C-B2186C365BF6Q26823434-26905350-EBBA-4BEA-BE2F-27EBACD46703Q26853120-85E860BD-E5AA-493A-9B6C-B4A0958A4B3CQ26853571-DC69DA2D-7AAC-451A-AE37-C1EF1085DE03Q26860929-C45555D5-6C3C-4448-AC05-30AAE17F75D0Q26861250-D075A82F-6600-4CDE-B558-14D9885DFEE1Q26864662-C7828E99-DCFF-42C4-BA00-4BD269789B51Q26997059-2B3D2D72-36DB-4B16-AC8A-B72515D893E4Q27000791-E9B188A1-A4FC-4BA8-A979-ADDF68BB483AQ27002928-3ECE47FC-5AB6-4BC9-9F76-75926ACC1E89Q27008807-841C18A5-482B-40F7-AB91-0682DF768533Q27012592-1D7ABBBC-CE45-4594-B9E6-A85C5AED41B8Q27016027-192E15D1-77E2-4E7D-BEFF-DDC6B52F6423Q27026332-6CA76A86-74BE-4CC8-BFB7-ACDDBE0A33F3Q27691392-60CAC61F-DDFE-4E7D-A0C6-CD6E5A11F492Q28066773-319D7A9A-7E5C-44F4-9BE8-961EECD0AC55Q28069411-77887315-3831-4D22-8405-9B7C6A5F6F61Q28071012-5FF37CA9-F94E-49A9-9CAA-E8EA61753306Q28071452-A6C834FE-AA3A-409A-8B06-0BFFE4C55458Q28072161-513B882D-DA80-4123-8D44-A43BB3169369Q28072229-9865E71C-2B86-482E-8723-2601B5EA9D41
P2860
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The effects of lowering LDL ch ...... ata from 27 randomised trials.
@ast
The effects of lowering LDL ch ...... ata from 27 randomised trials.
@en
The effects of lowering LDL ch ...... ata from 27 randomised trials.
@nl
type
label
The effects of lowering LDL ch ...... ata from 27 randomised trials.
@ast
The effects of lowering LDL ch ...... ata from 27 randomised trials.
@en
The effects of lowering LDL ch ...... ata from 27 randomised trials.
@nl
prefLabel
The effects of lowering LDL ch ...... ata from 27 randomised trials.
@ast
The effects of lowering LDL ch ...... ata from 27 randomised trials.
@en
The effects of lowering LDL ch ...... ata from 27 randomised trials.
@nl
P2093
P2860
P50
P1433
P1476
The effects of lowering LDL ch ...... ata from 27 randomised trials.
@en
P2093
Cholesterol Treatment Trialists' (CTT) Collaborators
E H Barnes
L Blackwell
P2860
P304
P356
10.1016/S0140-6736(12)60367-5
P407
P577
2012-05-17T00:00:00Z